BRIEF-Menarini Group And Insilico Medicine Enter A Second Exclusive Global License Agreement For An Ai Discovered Preclinical Asset Targeting High Unmet Needs In Oncology
ReutersJan 10, 2025 7:04 PM
Jan 10 (Reuters) - MENARINI GROUP :
MENARINI GROUP AND INSILICO MEDICINE ENTER A SECOND EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR AN AI DISCOVERED PRECLINICAL ASSET TARGETING HIGH UNMET NEEDS IN ONCOLOGY
MENARINI GROUP: DEAL INCLUDES $20M UPFRONT PAYMENT & COMBINED VALUE IS OVER $550 MILLION
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Related Articles
5 Key Numbers From Prologis’s Q4 2024 Earnings
TradingKey - Dividend investors have had a hard time given the higher interest rate environment imposed by the US Federal Reserve (Fed). Of course, interest rate cycles ebb and flow.TradingKey
22 hours ago
.jpg)
Oil retreats, but heads for weekly climb on potential Mideast supply disruption
SINGAPORE (Reuters) -Oil retreated on Friday after settling higher the previous day, but prices remained set for a second weekly gain as investors weighed the impact of hurricane damage on U.S. demand against any broad supply disruption if Israel attacks Iranian oil sites.Reuters
Fri, Oct 11
EUR/USD Price Forecast: Seems poised to surpass 1.1000 mark and retest YTD peak
EUR/USD regains positive traction on Friday amid the emergence of some USD selling.FXStreet
Fri, Aug 16
